APO-QUETIAPINE XR
APOTEX INC
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of APO-QUETIAPINE XR in Canada?
Yes. APO-QUETIAPINE XR 50MG has an active shortage reported to Health Canada (last updated November 14, 2024).
Why is APO-QUETIAPINE XR not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
When will APO-QUETIAPINE XR be available again?
No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.
Why Psychiatric Medications Keep Going Into Shortage in Canada
Why antidepressants and antipsychotics like buspirone, quetiapine, escitalopram, venlafaxine, and paroxetine show up in Canadian shortage reports so often, and what to do if yours is affected.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
⚠ Extended-release and immediate-release formulations are not interchangeable — confirm the release type with your pharmacist before switching.
Closest Matches
TEVA-QUETIAPINE XR
Extended-ReleaseTEVA CANADA LIMITED
Other Products
SEROQUEL
CHEPLAPHARM ARZNEIMITTEL GMBH
ACCEL-QUETIAPINE
ACCEL PHARMA INC
QUETIAPINE XR
Extended-ReleasePRO DOC LIMITEE
DOM-QUETIAPINE
DOMINION PHARMACAL
IPG-QUETIAPINE
MARCAN PHARMACEUTICALS INC
What this means
Does this mean my pharmacy is out of stock?
Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.
What should I do?
Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.
⚠ Possible Recall or Safety Alert
Health Canada has issued a recall or safety alert matching this product. This match is based on product name similarity and may not be exact — confirm against your specific lot number before taking action.
DIN
02457229
Strength
50MG
Dosage Form
TABLET (EXTENDED-RELEASE)
Route
ORAL
Compare with another product →
Shortage Timeline
Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.
Shortage History
Other Products from APOTEX INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
50MCG · DIN 02460513
325MG · DIN 02362341
500MG · DIN 02362368
DIN 02290901
325MG · DIN 02362422
500MG · DIN 02362244
10MG · DIN 02240414
20MG · DIN 02296098
150MG · DIN 02296160
75MG · DIN 02230507
2MG · DIN 02554194
2MG · DIN 02554178